Inspiremd Stock Price To Sales
| NSPR Stock | USD 3.00 0.02 0.67% |
InspireMD fundamentals help investors to digest information that contributes to InspireMD's financial success or failures. It also enables traders to predict the movement of InspireMD Stock. The fundamental analysis module provides a way to measure InspireMD's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InspireMD stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 10.99 | 10.44 |
InspireMD | Price To Sales |
InspireMD Company Price To Sales Analysis
InspireMD's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current InspireMD Price To Sales | 11.47 X |
Most of InspireMD's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InspireMD is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
InspireMD Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for InspireMD is extremely important. It helps to project a fair market value of InspireMD Stock properly, considering its historical fundamentals such as Price To Sales. Since InspireMD's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of InspireMD's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of InspireMD's interrelated accounts and indicators.
Click cells to compare fundamentals
InspireMD Price To Sales Historical Pattern
Today, most investors in InspireMD Stock are looking for potential investment opportunities by analyzing not only static indicators but also various InspireMD's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of InspireMD price to sales as a starting point in their analysis.
InspireMD Price To Sales |
| Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
InspireMD Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, InspireMD has a Price To Sales of 11.4721 times. This is 46.39% lower than that of the Health Care Equipment & Supplies sector and 140.0% higher than that of the Health Care industry. This indicator is about the same for all United States stocks average (which is currently at 11.42).
InspireMD Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InspireMD's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InspireMD could also be used in its relative valuation, which is a method of valuing InspireMD by comparing valuation metrics of similar companies.InspireMD is currently under evaluation in price to sales category among its peers.
InspireMD ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, InspireMD's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to InspireMD's managers, analysts, and investors.Environmental | Governance | Social |
InspireMD Fundamentals
| Return On Equity | -0.67 | ||||
| Return On Asset | -0.37 | ||||
| Operating Margin | (4.68) % | ||||
| Current Valuation | 39.86 M | ||||
| Shares Outstanding | 26.08 M | ||||
| Shares Owned By Insiders | 16.99 % | ||||
| Shares Owned By Institutions | 40.84 % | ||||
| Number Of Shares Shorted | 175.04 K | ||||
| Price To Earning | (0.16) X | ||||
| Price To Book | 1.91 X | ||||
| Price To Sales | 11.47 X | ||||
| Revenue | 6.21 M | ||||
| Gross Profit | 1.12 M | ||||
| EBITDA | (20.91 M) | ||||
| Net Income | (19.92 M) | ||||
| Cash And Equivalents | 26.47 M | ||||
| Cash Per Share | 3.18 X | ||||
| Total Debt | 1.59 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 6.26 X | ||||
| Book Value Per Share | 1.61 X | ||||
| Cash Flow From Operations | (16.38 M) | ||||
| Short Ratio | 2.26 X | ||||
| Earnings Per Share | (0.71) X | ||||
| Target Price | 4.75 | ||||
| Number Of Employees | 65 | ||||
| Beta | 0.93 | ||||
| Market Capitalization | 78.25 M | ||||
| Total Asset | 47.64 M | ||||
| Retained Earnings | (221.5 M) | ||||
| Working Capital | 38.14 M | ||||
| Current Asset | 4.63 M | ||||
| Current Liabilities | 6.83 M | ||||
| Net Asset | 47.64 M |
About InspireMD Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InspireMD's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InspireMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InspireMD based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with InspireMD
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.Moving together with InspireMD Stock
Moving against InspireMD Stock
| 0.63 | ENSG | Ensign Group | PairCorr |
| 0.62 | DRIO | DarioHealth Corp | PairCorr |
| 0.6 | EDAP | EDAP TMS SA | PairCorr |
| 0.49 | VTAK | Catheter Precision | PairCorr |
| 0.49 | EKSO | Ekso Bionics Holdings | PairCorr |
The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.
The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.